Page last updated: 2024-08-21

alpha-aminopyridine and Atherosclerosis

alpha-aminopyridine has been researched along with Atherosclerosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Glass, CK; Li, D; Liao, Z; Saltiel, AR; Shen, Z; Sun, X; Witztum, JL; Yu, H; Zhao, P1
Aouadi, M; Bhattacharya, SK; Buckbinder, L; Cooper, MP; Cortes, C; Czech, MP; Danai, LV; Fitzgibbons, TP; Hagan, N; Matevossian, A; Menendez, LG; Roth Flach, RJ; Skoura, A; Vangala, P; Yawe, JC; Zheng, W1
Anto-Michel, N; Blanz, KD; Bode, C; Braddock, M; Dufner, B; Geis, S; Gerhardt, LM; Gilsbach, R; Härdtner, C; Hawley, S; Heidt, T; Hein, L; Hergeth, SP; Hilgendorf, I; Hoppe, N; Kornemann, J; Libby, P; Lindau, A; McPheat, W; Robbins, CS; Stachon, P; Swirski, FK; von zur Mühlen, C; Willecke, F; Wolf, D; Zirlik, A; Zou, J1
Bode, C; Buchner, M; Colberg, C; Eisele, S; Hilgendorf, I; Hoppe, N; Lozhkin, A; Ortiz-Rodriguez, A; Remer, I; Schmitz, J; Stachon, P; von zur Muhlen, C; Willecke, F; Wolf, D; Zeschky, K; Zirlik, A; Zirlik, K; zur Hausen, A1

Other Studies

4 other study(ies) available for alpha-aminopyridine and Atherosclerosis

ArticleYear
The TBK1/IKKε inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis.
    JCI insight, 2022, 09-08, Volume: 7, Issue:17

    Topics: Aminopyridines; Animals; Atherosclerosis; Bile Acids and Salts; Diabetes Mellitus, Experimental; Humans; Hypercholesterolemia; I-kappa B Kinase; Mice; Protein Serine-Threonine Kinases

2022
Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis.
    Nature communications, 2015, Dec-21, Volume: 6

    Topics: Aminopyridines; Animals; Apolipoproteins E; Atherosclerosis; Endothelial Cells; Gene Expression Regulation; Inflammation; Macrophages; Male; Mice; Mice, Knockout; NF-kappa B; NF-kappaB-Inducing Kinase; Protein Serine-Threonine Kinases; Receptors, LDL; Vascular Diseases

2015
Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression.
    Basic research in cardiology, 2016, Volume: 111, Issue:2

    Topics: Aminopyridines; Animals; Atherosclerosis; Cell Adhesion; Cells, Cultured; Disease Progression; Drug Evaluation, Preclinical; Female; Intracellular Signaling Peptides and Proteins; Macrophages; Mice; Monocytes; Morpholines; Myelopoiesis; Oxazines; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Random Allocation; Syk Kinase

2016
The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:9

    Topics: Administration, Oral; Aminopyridines; Animals; Atherosclerosis; Cell Differentiation; Cell Movement; Cholesterol, Dietary; Inflammation; Intracellular Signaling Peptides and Proteins; Macrophages; Mice; Morpholines; Oxazines; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Receptors, LDL; Syk Kinase

2011